JP2016512555A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512555A5
JP2016512555A5 JP2016501805A JP2016501805A JP2016512555A5 JP 2016512555 A5 JP2016512555 A5 JP 2016512555A5 JP 2016501805 A JP2016501805 A JP 2016501805A JP 2016501805 A JP2016501805 A JP 2016501805A JP 2016512555 A5 JP2016512555 A5 JP 2016512555A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
aki
stem cells
placental stem
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016501805A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016512555A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/025266 external-priority patent/WO2014159826A1/en
Publication of JP2016512555A publication Critical patent/JP2016512555A/ja
Publication of JP2016512555A5 publication Critical patent/JP2016512555A5/ja
Pending legal-status Critical Current

Links

JP2016501805A 2013-03-14 2014-03-13 急性腎損傷の治療における胎盤幹細胞の使用 Pending JP2016512555A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361785252P 2013-03-14 2013-03-14
US61/785,252 2013-03-14
PCT/US2014/025266 WO2014159826A1 (en) 2013-03-14 2014-03-13 Use of placental stem cells in treatment of acute kidney injury

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018206365A Division JP2019055955A (ja) 2013-03-14 2018-11-01 急性腎損傷の治療における胎盤幹細胞の使用

Publications (2)

Publication Number Publication Date
JP2016512555A JP2016512555A (ja) 2016-04-28
JP2016512555A5 true JP2016512555A5 (cg-RX-API-DMAC7.html) 2017-04-13

Family

ID=51625261

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016501805A Pending JP2016512555A (ja) 2013-03-14 2014-03-13 急性腎損傷の治療における胎盤幹細胞の使用
JP2018206365A Pending JP2019055955A (ja) 2013-03-14 2018-11-01 急性腎損傷の治療における胎盤幹細胞の使用
JP2020180987A Withdrawn JP2021038229A (ja) 2013-03-14 2020-10-29 急性腎損傷の治療における胎盤幹細胞の使用
JP2022176132A Pending JP2023022018A (ja) 2013-03-14 2022-11-02 急性腎損傷の治療における胎盤幹細胞の使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018206365A Pending JP2019055955A (ja) 2013-03-14 2018-11-01 急性腎損傷の治療における胎盤幹細胞の使用
JP2020180987A Withdrawn JP2021038229A (ja) 2013-03-14 2020-10-29 急性腎損傷の治療における胎盤幹細胞の使用
JP2022176132A Pending JP2023022018A (ja) 2013-03-14 2022-11-02 急性腎損傷の治療における胎盤幹細胞の使用

Country Status (8)

Country Link
US (2) US20160030488A1 (cg-RX-API-DMAC7.html)
EP (1) EP2968420B1 (cg-RX-API-DMAC7.html)
JP (4) JP2016512555A (cg-RX-API-DMAC7.html)
DK (1) DK2968420T3 (cg-RX-API-DMAC7.html)
ES (1) ES2703784T3 (cg-RX-API-DMAC7.html)
PL (1) PL2968420T3 (cg-RX-API-DMAC7.html)
PT (1) PT2968420T (cg-RX-API-DMAC7.html)
WO (1) WO2014159826A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3548051A1 (en) * 2016-12-05 2019-10-09 Celularity, Inc. Treatment of lymphedema and related conditions using placental adherent cells
US10456419B2 (en) 2017-02-27 2019-10-29 Payman Sadeghi Method for treating migraine headaches
US10932711B2 (en) 2017-02-27 2021-03-02 Payman Sadeghi Method and system for neurohydrodissection

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
NZ534643A (en) * 2002-02-13 2010-06-25 Anthrogenesis Corp Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
US7910755B2 (en) * 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses
EP2471903B1 (en) * 2005-12-29 2018-02-14 Anthrogenesis Corporation Placental stem cell populations
CN101657206B (zh) * 2007-02-12 2013-07-03 人类起源公司 利用胎盘干细胞治疗炎性疾病
CN102036688B (zh) * 2007-10-05 2014-07-02 伊西康公司 使用人脐带组织来源的细胞进行肾脏组织的修复和再生
WO2009114826A2 (en) * 2008-03-13 2009-09-17 Angiodynamics, Inc. Treatment systems and methods for renal-related diseases
LT2556145T (lt) * 2010-04-07 2016-11-10 Anthrogenesis Corporation Angiogenezė naudojant placentos kamienines ląsteles
MX2012011543A (es) * 2010-04-08 2013-05-06 Anthrogenesis Corp Tratamiento de sarcoidosis empleando celulas madre placentarias.
JP2014520857A (ja) * 2011-07-15 2014-08-25 アントフロゲネシス コーポレーション 羊膜由来接着細胞を使用する放射線障害の治療

Similar Documents

Publication Publication Date Title
JP2013523152A5 (cg-RX-API-DMAC7.html)
SI3439660T1 (sl) Uporaba pimobendana za zmanjšanje velikosti srca in odložitev nastopa kliničnih simptomov pri pacientih z asimptomatsko srčno odpovedjo zaradi bolezni mitralne zaklopke
JP2016512555A5 (cg-RX-API-DMAC7.html)
JP2016512817A5 (cg-RX-API-DMAC7.html)
JP2014507482A5 (cg-RX-API-DMAC7.html)
JP2015535270A5 (cg-RX-API-DMAC7.html)
CN110114082A (zh) 一种预防和治疗脂肪代谢紊乱及其相关病症的方法
HRP20240798T1 (hr) Terapija matičnim stanicama kod patologija endometrija
JP2015535291A5 (cg-RX-API-DMAC7.html)
EA201491532A1 (ru) Фармацевтические композиции для использования в комплексной терапии
HK1232145A1 (zh) 雙功能化合物和用於降低尿酸水平的用途
PE20160221A1 (es) Formas de dosificacion farmaceuticas estabilizadas que comprenden atrasentan
IL285304A (en) Methods for treating symptoms and disorders associated with lysosomal storage diseases
JP2014513121A5 (cg-RX-API-DMAC7.html)
JP2014532758A5 (cg-RX-API-DMAC7.html)
JP2015516452A5 (cg-RX-API-DMAC7.html)
JP2013520509A5 (cg-RX-API-DMAC7.html)
JP2012525422A5 (cg-RX-API-DMAC7.html)
JP2015516450A5 (cg-RX-API-DMAC7.html)
WO2008100653A3 (en) Copper lowering treatment of cardiac disease
JP2015516449A5 (cg-RX-API-DMAC7.html)
RU2020121929A (ru) Фармацевтические комбинации
WO2015057403A3 (en) Compositions and methods for treatment of inflammatory bowel disease
HK40118605A (zh) 下尿路慢性炎症的治疗和诊断
Ji et al. Comparison of high flux hemodialysis with hemodialysis filtration on pro-inflammatory and oxidative stress related cytokines in uraemic peripheral blood mononuclear cells